340B Manufacturer Change Form - HRSA - hrsa 2026

Get Form
340B Manufacturer Change Form - HRSA - hrsa Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

Overview of the 340B Manufacturer Change Form

The 340B Manufacturer Change Form, issued by the Health Resources and Services Administration (HRSA), is a critical document used by pharmaceutical manufacturers. This form facilitates updates to manufacturer information concerning the Pharmaceutical Pricing Agreement. Specifically, it focuses on changes to contact details and addresses, ensuring all information remains current in official records. Utilizing this form is mandatory for compliance purposes and maintaining eligibility in the 340B Drug Pricing Program.

Steps to Complete the 340B Manufacturer Change Form

  1. Obtain the Form: Begin by accessing the 340B Manufacturer Change Form, which can typically be found on HRSA’s website.

  2. Fill in Manufacturer Details: Enter the current manufacturer details, ensuring every field matches existing information in HRSA’s records to avoid discrepancies.

  3. Update Contact Information: Accurately complete sections for new contact details or addresses. Double-check for any typos or omissions that could lead to processing delays.

  4. Authorization and Submission: Ensure the form is signed by an authorized person. HRSA requires an original authorizing signatory to commit to the adjustments stated.

  5. Submission: Submit the completed form via email as specified by HRSA guidelines. This prevents any potential delays associated with snail mail and ensures quicker processing.

Importance of the 340B Manufacturer Change Form

The 340B Manufacturer Change Form plays a vital role in keeping HRSA’s records up to date, allowing for accurate information flow between manufacturers and the administration. This is particularly important for compliance and ensuring that drugs are properly priced under the 340B program. Failure to maintain accurate information can lead to administrative holdups or compliance audits.

Who Typically Uses the 340B Manufacturer Change Form

The form is primarily used by pharmaceutical manufacturers participating in the 340B Drug Pricing Program. It is relevant for parties responsible for managing and updating official documentation related to the program, including administrative staff within pharmaceutical companies and authorized management personnel.

decoration image ratings of Dochub

Key Elements of the 340B Manufacturer Change Form

  • Manufacturer Identification: Includes fields for identifying the manufacturer using unique identifiers as per HRSA’s records.
  • Contact Information: Sections dedicated to detailing contact and location changes.
  • Authorization: Mandatory signature area for an authorized individual within the manufacturer’s organization to affirm and authorize the changes.

Form Submission Methods

HRSA stipulates that the preferred method of submitting the 340B Manufacturer Change Form is via email. This allows more immediate updating of records and facilitates quicker communication. Paper submissions may result in delays and are generally discouraged unless specified by HRSA.

Legal Considerations and Use

Compliance with HRSA’s requirements for update submissions is crucial. The legal foundation ensures that all pharmaceutical pricing remains transparent, accurate, and within agreed-upon frameworks. Manufacturers must adhere strictly to these guidelines to avoid any legal challenges or potential roadblocks in maintaining 340B program eligibility.

Required Documents for Submission

When updating information via the 340B Manufacturer Change Form, manufacturers must ensure they provide any additional documentation that supports the changes made. This might include corporate resolutions authorizing new signatories or address verification documents. Keeping these prepared and ready to submit alongside the form will aid in seamless processing.

Common State-Specific Concerns

While the 340B Manufacturer Change Form is a federal document, manufacturers should remain aware of any state-specific regulations affecting pharmaceutical pricing agreements. Differences in state regulations may not directly alter the form's process but could influence the broader compliance environment. Always consult with legal counsel to navigate state-specific requirements effectively.

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
256b, imposes a ceiling price that limits the prices that drug manufacturers may charge for drugs sold to specified health care facilities and entities, known as 340B entities.
Section 340B(a)(4) of the Public Health Service Act (PHS) Act (42 U.S.C. 256b) lists eligible organizations that can participate in and purchase discounted drugs under the 340B Program. HRSAs Office of Pharmacy Affairs (OPA) requires registration and approval for covered entities to participate in the 340B Program.
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients.
340B registration RegisterStart Date January 1 15 April 1 April 1 15 July 1 July 1 15 October 1 October 1 15 January 1
The authorizing statuteSection 340B of the Public Health Service Act (42 U.S.C. 256b)requires drug manufacturers that participate in the Medicaid Program to offer certain outpatient drugs to covered entities at discounted prices.

Security and compliance

At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.

Learn more
ccpa2
pci-dss
gdpr-compliance
hipaa
soc-compliance
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Recertification 340B covered entities must annually redocHub their eligibility to remain in the 340B Program and continue purchasing covered outpatient drugs at discounted 340B prices.
42 U.S. Code 254b - Health centers. as may be appropriate for particular centers, additional health services (as defined in subsection (b)(2)) necessary for the adequate support of the primary health services required under subparagraph (A);

Related links